Beyond the Abstract — Treatment options for localized prostate cancer

The following article, by Ravinder Mohan, MD, PhD, is reproduced from the UroToday web site with kind permission of Dr. Mohan and the publishers of UroToday. We had previously commented on the original article, published last month in American Family Physician.

Patients’ decisions, patients’ expectations, and surgery for localized prostate cancer

Two articles and an associated editorial, currently in press in the Journal of Urology, offer insight into the pre-treatment expectations and the post-treatment realities of men who decide to have surgical treatment for localized prostate cancer.

How young men have thought about treatment options for Gleason 6 prostate cancer

A new study based on data from nearly 500 patients gives us some insight into how a selected group of men less than 50 years of age were thinking about treatment for prostate cancer between 2001 and 2005. Whether one would get the same results for a similar group of patient diagnosed today is a good [...]

PCPs’ opinions about PSA testing and “shared decision-making”

A report in Family Medicine gives us some insight into the views of primary care physicians (PCPs) with respect to PSA testing for prostate cancer risk and the appropriate roles of the patient and the physician in the decision to have or not have PSA tests.

Prostate cancer treatment in southwestern Georgia: race and a rural environment

A new study just published in Urology seems to confirm facts that have previously been identified in earlier studies of how men elect to get treated for localized prostate cancer in parts of the USA with a high proportion of African American residents and relatively low income levels.

Where you live affects your prostate cancer treatment

If you are a Medicare patient, where you live may have a profound effect on how you get treated for localized prostate cancer (among other things), according to a new report from The Dartmouth Institute for Health Policy and Clinical Practice.

Partner participation in prostate cancer treatment decision-making

Men are often torn between involving their family members in health-care decision-making and trying to keep the whole issue to themselves because they just “don’t want to make a big deal about it.” But prostate cancer is a big deal — for the patient and for his immediate family.

More from the AUA in San Francisco

The most interesting thing about the educational process at the AUA this year is the increasing appreciation of the complexity of the decision-making processes required by patients and their doctors as regards prostate cancer risk and management.

How preconceptions impact prostate cancer management

As Leah wrote in a comment on this blog just the other day, “Yes, the ‘D-word’ is still taboo. Death is UNAMERICAN.” The comment stimulated the thought that our preconceptions have significant impact on how we think about risk, diagnosis, and treatment of prostate cancer — and yet there is really very little good research on [...]

Shopping for care in the prostate cancer “treatment bazaar”

A recent article (and an associated editorial) in the Archives of Internal Medicine evaluated how visits to specialists and primary care physicians (PCPs) by men with localized prostate cancer are related to treatment choice.

Where do newly diagnosed patients seek information?

A recent report in Urology focused on the role of information sources in the treatment decision-making process of men diagnosed with localized prostate cancer.

Tuesday’s news for October 7

Today’s news addresses the wide range of “predictive tools” now available to offer prognostic guidance in the management of prostate cancer and the ways in which personality affects treatment decision-making.

Follow

Get every new post delivered to your Inbox.

Join 269 other followers